Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.

The purpose of this report was to investigate the feasibility of using disk intrinsic dissolution rate (DIDR) to determine solubility class membership. We employed a VanKel dissolution apparatus fitted with a Wood's intrinsic dissolution die. To test the robustness of the method, variations of DIDR with compression force, dissolution volume, distance of the drug disk from the bottom of the dissolution vessel, and drug disk rotation speed were studied using furosemide and metoprolol in pH 4.5 acetate buffer as a model system. The DIDRs of six low solubility and nine high solubility model drugs were then determined at pH 1.2, 4.5, and 6.8 and compared to their BCS solubility class membership. It was found that the compression force, dissolution medium volume, and die position had no significant effect on DIDR for the system studied. The proposed compression force, dissolution volume, die position, and rotation speed are 2000 psi, 900 ml, 0.5 in., and 100 rpm, respectively. The test results obtained from 15 model BCS drugs show a good relationship between the DIDR and BCS solubility classification with 0.1 mg/min/cm(2) as a class boundary unless the dose is either extremely low or high where discrepancies may exist between the solubility and DIDR methods. Therefore, more scientific research and debates are needed before considered for regulatory purpose.

[1]  G L Amidon,et al.  Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. , 2000, Journal of pharmaceutical sciences.

[2]  V. Sunderland,et al.  Solubilities and intrinsic dissolution rates of sulphamethoxazole and trimethoprim , 1987, The Journal of pharmacy and pharmacology.

[3]  David J.W. Grant,et al.  Influence of compaction on the intrinsic dissolution rate of modified acetaminophen and adipic acid crystals , 1989 .

[4]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[5]  Lawrence X. Yu An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.

[6]  J. Wood,et al.  Improved holder for intrinsic dissolution rate studies. , 1965, Journal of pharmaceutical sciences.

[7]  G. Reier,et al.  Use of intrinsic dissolution rates to determine thermodynamic parameters associated with phase transitions. , 1972, Journal of pharmaceutical sciences.

[8]  Elizabeth M. Topp,et al.  Transport processes in pharmaceutical systems , 1999 .

[9]  Michael Levin Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[10]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[11]  G. Amidon,et al.  Theoretical and experimental studies of transport of micelle-solubilized solutes. , 1982, Journal of pharmaceutical sciences.